Haemonetics Corp. buy Raymond James
Start price
07.02.25
/
50%
€57.00
Target price
07.02.26
€111.41
Performance (%)
18.42%
Price
22.12.25
€68.50
Summary
This prediction is currently active. The prediction currently has a performance of 18.42%. This prediction currently runs until 07.02.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | - | - |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Raymond_James for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Raymond_James for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
09.05.25
09.05.25
€93.63
09.05.26
09.05.26
12.50%
22.12.25
22.12.25
